Tegaserod maleate

CAS No. 189188-57-6

Tegaserod maleate( SDZ-HTF 919 | Zelnorm )

Catalog No. M12965 CAS No. 189188-57-6

Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 65 In Stock
50MG 110 In Stock
100MG 188 In Stock
200MG 285 In Stock
500MG 482 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tegaserod maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.
  • Description
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome.
  • In Vitro
    Apoptosis Analysis Cell Line:A375, RPMI-7951 (RPMI), SH4, B16F10, MeWo and MEL-JUSO.Concentration:3, 5 μM Incubation Time:24, 48, 72 h Result:There was a significant time and dose-dependent increase in apoptosis in all cell lines.Western Blot Analysis Cell Line:RPMI, SH4 and B16F10 cells.Concentration:3, 5 μM Incubation Time:8 or 18?h Result:Decreased phosphorylation of the kinase directly upstream of S6, p70 S6 at Thr421/Ser424.
  • In Vivo
    Animal Model:C57BL/6?J mice were subcutaneously injected with B16F10 cellsDosage:5?mg/kg Administration:Administered intraperitoneally (i.p.) daily for five consecutive days Result:Treatment significantly decreased tumor growth and resulted in only slight decreases in weight following treatment.Animal Model:Female C57BLKS/J db/db mice Dosage:0.1, 0.5, 1.0, 2.0 mg/kg Administration:IP; 15 min prior to gastric loading Result:Produced a dramatic decrease in the fraction of the meal remaining in the stomach for doses as low as 0.1 mg/kg (0.1 mg/kg).Accelerated gastric emptying, with a reduction of nearly 80% in the fraction remaining at 30 min (P < 0.0001) (0.1 mg/kg).Induced a significant decrease in the gastric emptying rate as the amount of the meal remaining at 30 min was significantly greater (2.0 mg/kg).Resulted in inhibition of tegaserod-induced increased gastric emptying (0.1 mg/kg).
  • Synonyms
    SDZ-HTF 919 | Zelnorm
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT| Sert (Sodium-dependent)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    189188-57-6
  • Formula Weight
    417.46
  • Molecular Formula
    C20H27N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 35mg/mL
  • SMILES
    CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)OC.C(=C\C(=O)O)\C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Beattie DT, et al. Br J Pharmacol. 2004 Nov;143(5):549-60.
molnova catalog
related products
  • cis-Urocanic acid

    cis-Urocanic acid is a 5-HT2A receptor agonist (Kd: 4.6 nM). It is an immune modulator that induces immunosuppression by binding to the 5-HT2A receptor.

  • Alverine citrate

    Alverine Citrate(NSC35459) is a drug used for functional gastrointestinal disorders.

  • SB-616234-A

    SB-616234-A is a selective and orally bioavailable antagonist of 5-HT1B receptor, with anxiolytic and antidepressant activity.